Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)

Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)

US Patent 10011659 · Granted Jul 3, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti amphiregulin antibodies, compositions comprising same and uses thereof2020
Anti-HER3 antibodies and uses of same2020
Anti-HER3 antibodies and uses of same2020
Neuregulin allosteric anti-HER3 antibody2019
Aptamers, multimeric aptamers and uses thereof2018
Antibodies and methods of using same for treating ErbB/ErbB ligands associated d2016
Combination therapy to prevent DCIS formation and progression to breast cancer2016
Antibody combinations and use of same for treating cancer2016
Antibodies against HER32016
Anti-human HER3 antibodies and uses thereof2015
Combinations of anti ErbB antibodies for the treatment of cancer2015
Antibody combinations and use of same for treating cancer2014